nodes	percent_of_prediction	percent_of_DWPC	metapath
Disopyramide—CYP3A4—bone cancer	0.9	1	CbGaD
Disopyramide—SLC22A2—Cisplatin—bone cancer	0.0083	0.904	CbGbCtD
Disopyramide—Cardiogenic shock—Epirubicin—bone cancer	0.00325	0.038	CcSEcCtD
Disopyramide—Cardiogenic shock—Doxorubicin—bone cancer	0.003	0.0352	CcSEcCtD
Disopyramide—Fesoterodine—CYP3A4—bone cancer	0.00208	0.427	CrCbGaD
Disopyramide—Pain—Carboplatin—bone cancer	0.00138	0.0161	CcSEcCtD
Disopyramide—Bundle branch block—Epirubicin—bone cancer	0.00135	0.0158	CcSEcCtD
Disopyramide—Body temperature increased—Carboplatin—bone cancer	0.00127	0.0149	CcSEcCtD
Disopyramide—Bundle branch block—Doxorubicin—bone cancer	0.00125	0.0146	CcSEcCtD
Disopyramide—Cardiac failure congestive—Cisplatin—bone cancer	0.00106	0.0124	CcSEcCtD
Disopyramide—Cyanosis—Methotrexate—bone cancer	0.00103	0.012	CcSEcCtD
Disopyramide—Tolterodine—CYP3A4—bone cancer	0.00093	0.191	CrCbGaD
Disopyramide—Blood creatinine increased—Cisplatin—bone cancer	0.000901	0.0105	CcSEcCtD
Disopyramide—CYP3A4—Doxorubicin—bone cancer	0.000887	0.0966	CbGbCtD
Disopyramide—Hypokalaemia—Cisplatin—bone cancer	0.000875	0.0102	CcSEcCtD
Disopyramide—Feeling hot—Epirubicin—bone cancer	0.000867	0.0101	CcSEcCtD
Disopyramide—Apnoea—Methotrexate—bone cancer	0.000858	0.01	CcSEcCtD
Disopyramide—Sweating increased—Cisplatin—bone cancer	0.00081	0.00948	CcSEcCtD
Disopyramide—Feeling hot—Doxorubicin—bone cancer	0.000802	0.00939	CcSEcCtD
Disopyramide—Jaundice cholestatic—Epirubicin—bone cancer	0.000775	0.00907	CcSEcCtD
Disopyramide—Hepatic enzyme increased—Methotrexate—bone cancer	0.000769	0.009	CcSEcCtD
Disopyramide—Levomethadyl Acetate—CYP3A4—bone cancer	0.000758	0.156	CrCbGaD
Disopyramide—Jaundice cholestatic—Doxorubicin—bone cancer	0.000717	0.00839	CcSEcCtD
Disopyramide—Creatinine increased—Epirubicin—bone cancer	0.000715	0.00837	CcSEcCtD
Disopyramide—Atrioventricular block—Epirubicin—bone cancer	0.000702	0.00821	CcSEcCtD
Disopyramide—Ventricular tachycardia—Epirubicin—bone cancer	0.000681	0.00797	CcSEcCtD
Disopyramide—Bradycardia—Cisplatin—bone cancer	0.000677	0.00793	CcSEcCtD
Disopyramide—Coma—Methotrexate—bone cancer	0.000664	0.00778	CcSEcCtD
Disopyramide—Creatinine increased—Doxorubicin—bone cancer	0.000661	0.00774	CcSEcCtD
Disopyramide—Dextropropoxyphene—CYP3A4—bone cancer	0.000655	0.135	CrCbGaD
Disopyramide—Gynaecomastia—Methotrexate—bone cancer	0.000651	0.00762	CcSEcCtD
Disopyramide—Atrioventricular block—Doxorubicin—bone cancer	0.000649	0.0076	CcSEcCtD
Disopyramide—Blood urea increased—Epirubicin—bone cancer	0.000642	0.00752	CcSEcCtD
Disopyramide—Ventricular tachycardia—Doxorubicin—bone cancer	0.00063	0.00737	CcSEcCtD
Disopyramide—Dry eye—Epirubicin—bone cancer	0.000629	0.00736	CcSEcCtD
Disopyramide—Coma—Epirubicin—bone cancer	0.000622	0.00728	CcSEcCtD
Disopyramide—Arrhythmia—Cisplatin—bone cancer	0.000594	0.00696	CcSEcCtD
Disopyramide—Blood urea increased—Doxorubicin—bone cancer	0.000594	0.00696	CcSEcCtD
Disopyramide—Dry eye—Doxorubicin—bone cancer	0.000582	0.00681	CcSEcCtD
Disopyramide—Coma—Doxorubicin—bone cancer	0.000575	0.00673	CcSEcCtD
Disopyramide—Flatulence—Cisplatin—bone cancer	0.000571	0.00668	CcSEcCtD
Disopyramide—Vision blurred—Cisplatin—bone cancer	0.000546	0.00639	CcSEcCtD
Disopyramide—Cardiac failure congestive—Epirubicin—bone cancer	0.000545	0.00638	CcSEcCtD
Disopyramide—Ill-defined disorder—Cisplatin—bone cancer	0.000538	0.00629	CcSEcCtD
Disopyramide—Malaise—Cisplatin—bone cancer	0.000522	0.00611	CcSEcCtD
Disopyramide—Hypoglycaemia—Epirubicin—bone cancer	0.000506	0.00592	CcSEcCtD
Disopyramide—Cardiac failure—Epirubicin—bone cancer	0.000506	0.00592	CcSEcCtD
Disopyramide—Cardiac failure congestive—Doxorubicin—bone cancer	0.000504	0.0059	CcSEcCtD
Disopyramide—Diplopia—Epirubicin—bone cancer	0.000494	0.00578	CcSEcCtD
Disopyramide—Discomfort—Cisplatin—bone cancer	0.000487	0.0057	CcSEcCtD
Disopyramide—Oedema—Cisplatin—bone cancer	0.000473	0.00553	CcSEcCtD
Disopyramide—Cardiac arrest—Epirubicin—bone cancer	0.00047	0.0055	CcSEcCtD
Disopyramide—Hypoglycaemia—Doxorubicin—bone cancer	0.000468	0.00548	CcSEcCtD
Disopyramide—Cardiac failure—Doxorubicin—bone cancer	0.000468	0.00548	CcSEcCtD
Disopyramide—Thrombocytopenia—Cisplatin—bone cancer	0.000463	0.00542	CcSEcCtD
Disopyramide—Blood creatinine increased—Epirubicin—bone cancer	0.000463	0.00542	CcSEcCtD
Disopyramide—Skin disorder—Cisplatin—bone cancer	0.000459	0.00538	CcSEcCtD
Disopyramide—Diplopia—Doxorubicin—bone cancer	0.000457	0.00535	CcSEcCtD
Disopyramide—Hyperhidrosis—Cisplatin—bone cancer	0.000457	0.00535	CcSEcCtD
Disopyramide—Abdominal pain upper—Epirubicin—bone cancer	0.000451	0.00528	CcSEcCtD
Disopyramide—Anorexia—Cisplatin—bone cancer	0.000451	0.00527	CcSEcCtD
Disopyramide—Hypokalaemia—Epirubicin—bone cancer	0.00045	0.00526	CcSEcCtD
Disopyramide—Methadone—CYP3A4—bone cancer	0.000444	0.0913	CrCbGaD
Disopyramide—Hypotension—Cisplatin—bone cancer	0.000442	0.00517	CcSEcCtD
Disopyramide—Muscular weakness—Epirubicin—bone cancer	0.000436	0.0051	CcSEcCtD
Disopyramide—Cardiac arrest—Doxorubicin—bone cancer	0.000435	0.00509	CcSEcCtD
Disopyramide—Abdominal distension—Epirubicin—bone cancer	0.00043	0.00503	CcSEcCtD
Disopyramide—Blood creatinine increased—Doxorubicin—bone cancer	0.000428	0.00501	CcSEcCtD
Disopyramide—Dysuria—Methotrexate—bone cancer	0.000427	0.00499	CcSEcCtD
Disopyramide—Neutropenia—Methotrexate—bone cancer	0.000427	0.00499	CcSEcCtD
Disopyramide—Paraesthesia—Cisplatin—bone cancer	0.000425	0.00497	CcSEcCtD
Disopyramide—Dyspnoea—Cisplatin—bone cancer	0.000422	0.00493	CcSEcCtD
Disopyramide—Erectile dysfunction—Methotrexate—bone cancer	0.00042	0.00492	CcSEcCtD
Disopyramide—Abdominal pain upper—Doxorubicin—bone cancer	0.000417	0.00489	CcSEcCtD
Disopyramide—Hypokalaemia—Doxorubicin—bone cancer	0.000416	0.00487	CcSEcCtD
Disopyramide—Decreased appetite—Cisplatin—bone cancer	0.000411	0.00481	CcSEcCtD
Disopyramide—Drowsiness—Methotrexate—bone cancer	0.000407	0.00476	CcSEcCtD
Disopyramide—Depression—Methotrexate—bone cancer	0.000406	0.00475	CcSEcCtD
Disopyramide—Pain—Cisplatin—bone cancer	0.000404	0.00473	CcSEcCtD
Disopyramide—Muscular weakness—Doxorubicin—bone cancer	0.000403	0.00472	CcSEcCtD
Disopyramide—Dysuria—Epirubicin—bone cancer	0.000399	0.00467	CcSEcCtD
Disopyramide—Neutropenia—Epirubicin—bone cancer	0.000399	0.00467	CcSEcCtD
Disopyramide—Abdominal distension—Doxorubicin—bone cancer	0.000398	0.00465	CcSEcCtD
Disopyramide—Pollakiuria—Epirubicin—bone cancer	0.000394	0.00462	CcSEcCtD
Disopyramide—Feeling abnormal—Cisplatin—bone cancer	0.00039	0.00456	CcSEcCtD
Disopyramide—Weight increased—Epirubicin—bone cancer	0.000389	0.00455	CcSEcCtD
Disopyramide—Drowsiness—Epirubicin—bone cancer	0.000381	0.00446	CcSEcCtD
Disopyramide—Agranulocytosis—Methotrexate—bone cancer	0.00038	0.00444	CcSEcCtD
Disopyramide—Body temperature increased—Cisplatin—bone cancer	0.000374	0.00437	CcSEcCtD
Disopyramide—Neutropenia—Doxorubicin—bone cancer	0.000369	0.00432	CcSEcCtD
Disopyramide—Dysuria—Doxorubicin—bone cancer	0.000369	0.00432	CcSEcCtD
Disopyramide—Hepatitis—Methotrexate—bone cancer	0.000365	0.00427	CcSEcCtD
Disopyramide—Pollakiuria—Doxorubicin—bone cancer	0.000365	0.00427	CcSEcCtD
Disopyramide—Weight increased—Doxorubicin—bone cancer	0.00036	0.00421	CcSEcCtD
Disopyramide—Agranulocytosis—Epirubicin—bone cancer	0.000355	0.00416	CcSEcCtD
Disopyramide—Drowsiness—Doxorubicin—bone cancer	0.000352	0.00412	CcSEcCtD
Disopyramide—Bradycardia—Epirubicin—bone cancer	0.000348	0.00407	CcSEcCtD
Disopyramide—Hepatitis—Epirubicin—bone cancer	0.000342	0.004	CcSEcCtD
Disopyramide—Hypoaesthesia—Epirubicin—bone cancer	0.00034	0.00398	CcSEcCtD
Disopyramide—Asthenia—Cisplatin—bone cancer	0.000339	0.00397	CcSEcCtD
Disopyramide—Agranulocytosis—Doxorubicin—bone cancer	0.000329	0.00385	CcSEcCtD
Disopyramide—Diarrhoea—Cisplatin—bone cancer	0.000323	0.00379	CcSEcCtD
Disopyramide—Bradycardia—Doxorubicin—bone cancer	0.000322	0.00377	CcSEcCtD
Disopyramide—Hepatitis—Doxorubicin—bone cancer	0.000316	0.0037	CcSEcCtD
Disopyramide—Hypoaesthesia—Doxorubicin—bone cancer	0.000315	0.00368	CcSEcCtD
Disopyramide—Dysgeusia—Methotrexate—bone cancer	0.000311	0.00364	CcSEcCtD
Disopyramide—Arrhythmia—Epirubicin—bone cancer	0.000305	0.00357	CcSEcCtD
Disopyramide—Vomiting—Cisplatin—bone cancer	0.000301	0.00352	CcSEcCtD
Disopyramide—Vision blurred—Methotrexate—bone cancer	0.0003	0.00351	CcSEcCtD
Disopyramide—Rash—Cisplatin—bone cancer	0.000298	0.00349	CcSEcCtD
Disopyramide—Dermatitis—Cisplatin—bone cancer	0.000298	0.00349	CcSEcCtD
Disopyramide—Ill-defined disorder—Methotrexate—bone cancer	0.000295	0.00345	CcSEcCtD
Disopyramide—Flatulence—Epirubicin—bone cancer	0.000293	0.00343	CcSEcCtD
Disopyramide—Tension—Epirubicin—bone cancer	0.000292	0.00342	CcSEcCtD
Disopyramide—Dysgeusia—Epirubicin—bone cancer	0.000291	0.00341	CcSEcCtD
Disopyramide—Nervousness—Epirubicin—bone cancer	0.000289	0.00338	CcSEcCtD
Disopyramide—Malaise—Methotrexate—bone cancer	0.000287	0.00336	CcSEcCtD
Disopyramide—Vertigo—Methotrexate—bone cancer	0.000286	0.00334	CcSEcCtD
Disopyramide—Arrhythmia—Doxorubicin—bone cancer	0.000282	0.00331	CcSEcCtD
Disopyramide—Nausea—Cisplatin—bone cancer	0.000281	0.00329	CcSEcCtD
Disopyramide—Vision blurred—Epirubicin—bone cancer	0.00028	0.00328	CcSEcCtD
Disopyramide—Ill-defined disorder—Epirubicin—bone cancer	0.000276	0.00323	CcSEcCtD
Disopyramide—Flatulence—Doxorubicin—bone cancer	0.000271	0.00317	CcSEcCtD
Disopyramide—Chest pain—Methotrexate—bone cancer	0.000271	0.00317	CcSEcCtD
Disopyramide—Tension—Doxorubicin—bone cancer	0.00027	0.00316	CcSEcCtD
Disopyramide—Dysgeusia—Doxorubicin—bone cancer	0.00027	0.00315	CcSEcCtD
Disopyramide—Malaise—Epirubicin—bone cancer	0.000268	0.00314	CcSEcCtD
Disopyramide—Discomfort—Methotrexate—bone cancer	0.000267	0.00313	CcSEcCtD
Disopyramide—Nervousness—Doxorubicin—bone cancer	0.000267	0.00313	CcSEcCtD
Disopyramide—Vertigo—Epirubicin—bone cancer	0.000267	0.00313	CcSEcCtD
Disopyramide—Syncope—Epirubicin—bone cancer	0.000267	0.00312	CcSEcCtD
Disopyramide—Confusional state—Methotrexate—bone cancer	0.000262	0.00306	CcSEcCtD
Disopyramide—Loss of consciousness—Epirubicin—bone cancer	0.000261	0.00306	CcSEcCtD
Disopyramide—Vision blurred—Doxorubicin—bone cancer	0.000259	0.00304	CcSEcCtD
Disopyramide—Ill-defined disorder—Doxorubicin—bone cancer	0.000255	0.00299	CcSEcCtD
Disopyramide—Thrombocytopenia—Methotrexate—bone cancer	0.000254	0.00297	CcSEcCtD
Disopyramide—Chest pain—Epirubicin—bone cancer	0.000253	0.00296	CcSEcCtD
Disopyramide—Skin disorder—Methotrexate—bone cancer	0.000252	0.00295	CcSEcCtD
Disopyramide—Hyperhidrosis—Methotrexate—bone cancer	0.000251	0.00294	CcSEcCtD
Disopyramide—Discomfort—Epirubicin—bone cancer	0.00025	0.00293	CcSEcCtD
Disopyramide—Malaise—Doxorubicin—bone cancer	0.000248	0.00291	CcSEcCtD
Disopyramide—Dry mouth—Epirubicin—bone cancer	0.000248	0.0029	CcSEcCtD
Disopyramide—Vertigo—Doxorubicin—bone cancer	0.000247	0.00289	CcSEcCtD
Disopyramide—Anorexia—Methotrexate—bone cancer	0.000247	0.00289	CcSEcCtD
Disopyramide—Syncope—Doxorubicin—bone cancer	0.000247	0.00289	CcSEcCtD
Disopyramide—Confusional state—Epirubicin—bone cancer	0.000245	0.00287	CcSEcCtD
Disopyramide—Oedema—Epirubicin—bone cancer	0.000243	0.00284	CcSEcCtD
Disopyramide—Hypotension—Methotrexate—bone cancer	0.000242	0.00284	CcSEcCtD
Disopyramide—Loss of consciousness—Doxorubicin—bone cancer	0.000242	0.00283	CcSEcCtD
Disopyramide—Shock—Epirubicin—bone cancer	0.000239	0.0028	CcSEcCtD
Disopyramide—Thrombocytopenia—Epirubicin—bone cancer	0.000238	0.00278	CcSEcCtD
Disopyramide—Skin disorder—Epirubicin—bone cancer	0.000236	0.00276	CcSEcCtD
Disopyramide—Hyperhidrosis—Epirubicin—bone cancer	0.000235	0.00275	CcSEcCtD
Disopyramide—Insomnia—Methotrexate—bone cancer	0.000235	0.00275	CcSEcCtD
Disopyramide—Chest pain—Doxorubicin—bone cancer	0.000234	0.00274	CcSEcCtD
Disopyramide—Paraesthesia—Methotrexate—bone cancer	0.000233	0.00273	CcSEcCtD
Disopyramide—Discomfort—Doxorubicin—bone cancer	0.000232	0.00271	CcSEcCtD
Disopyramide—Anorexia—Epirubicin—bone cancer	0.000231	0.00271	CcSEcCtD
Disopyramide—Dyspnoea—Methotrexate—bone cancer	0.000231	0.00271	CcSEcCtD
Disopyramide—Somnolence—Methotrexate—bone cancer	0.000231	0.0027	CcSEcCtD
Disopyramide—Dry mouth—Doxorubicin—bone cancer	0.000229	0.00268	CcSEcCtD
Disopyramide—Dyspepsia—Methotrexate—bone cancer	0.000228	0.00267	CcSEcCtD
Disopyramide—Hypotension—Epirubicin—bone cancer	0.000227	0.00266	CcSEcCtD
Disopyramide—Confusional state—Doxorubicin—bone cancer	0.000227	0.00265	CcSEcCtD
Disopyramide—Decreased appetite—Methotrexate—bone cancer	0.000226	0.00264	CcSEcCtD
Disopyramide—Oedema—Doxorubicin—bone cancer	0.000225	0.00263	CcSEcCtD
Disopyramide—Fatigue—Methotrexate—bone cancer	0.000224	0.00262	CcSEcCtD
Disopyramide—Pain—Methotrexate—bone cancer	0.000222	0.0026	CcSEcCtD
Disopyramide—Shock—Doxorubicin—bone cancer	0.000221	0.00259	CcSEcCtD
Disopyramide—Thrombocytopenia—Doxorubicin—bone cancer	0.00022	0.00257	CcSEcCtD
Disopyramide—Insomnia—Epirubicin—bone cancer	0.00022	0.00257	CcSEcCtD
Disopyramide—Skin disorder—Doxorubicin—bone cancer	0.000218	0.00255	CcSEcCtD
Disopyramide—Paraesthesia—Epirubicin—bone cancer	0.000218	0.00255	CcSEcCtD
Disopyramide—Hyperhidrosis—Doxorubicin—bone cancer	0.000217	0.00254	CcSEcCtD
Disopyramide—Dyspnoea—Epirubicin—bone cancer	0.000216	0.00253	CcSEcCtD
Disopyramide—Somnolence—Epirubicin—bone cancer	0.000216	0.00253	CcSEcCtD
Disopyramide—Anorexia—Doxorubicin—bone cancer	0.000214	0.00251	CcSEcCtD
Disopyramide—Feeling abnormal—Methotrexate—bone cancer	0.000214	0.0025	CcSEcCtD
Disopyramide—Dyspepsia—Epirubicin—bone cancer	0.000214	0.0025	CcSEcCtD
Disopyramide—Decreased appetite—Epirubicin—bone cancer	0.000211	0.00247	CcSEcCtD
Disopyramide—Hypotension—Doxorubicin—bone cancer	0.00021	0.00246	CcSEcCtD
Disopyramide—Fatigue—Epirubicin—bone cancer	0.000209	0.00245	CcSEcCtD
Disopyramide—Pain—Epirubicin—bone cancer	0.000208	0.00243	CcSEcCtD
Disopyramide—Constipation—Epirubicin—bone cancer	0.000208	0.00243	CcSEcCtD
Disopyramide—Urticaria—Methotrexate—bone cancer	0.000206	0.00241	CcSEcCtD
Disopyramide—Body temperature increased—Methotrexate—bone cancer	0.000205	0.0024	CcSEcCtD
Disopyramide—Insomnia—Doxorubicin—bone cancer	0.000203	0.00238	CcSEcCtD
Disopyramide—Paraesthesia—Doxorubicin—bone cancer	0.000202	0.00236	CcSEcCtD
Disopyramide—Dyspnoea—Doxorubicin—bone cancer	0.0002	0.00234	CcSEcCtD
Disopyramide—Feeling abnormal—Epirubicin—bone cancer	0.0002	0.00234	CcSEcCtD
Disopyramide—Somnolence—Doxorubicin—bone cancer	0.0002	0.00234	CcSEcCtD
Disopyramide—Dyspepsia—Doxorubicin—bone cancer	0.000198	0.00231	CcSEcCtD
Disopyramide—Decreased appetite—Doxorubicin—bone cancer	0.000195	0.00229	CcSEcCtD
Disopyramide—Fatigue—Doxorubicin—bone cancer	0.000194	0.00227	CcSEcCtD
Disopyramide—Urticaria—Epirubicin—bone cancer	0.000193	0.00226	CcSEcCtD
Disopyramide—Pain—Doxorubicin—bone cancer	0.000192	0.00225	CcSEcCtD
Disopyramide—Constipation—Doxorubicin—bone cancer	0.000192	0.00225	CcSEcCtD
Disopyramide—Body temperature increased—Epirubicin—bone cancer	0.000192	0.00225	CcSEcCtD
Disopyramide—Asthenia—Methotrexate—bone cancer	0.000186	0.00218	CcSEcCtD
Disopyramide—Feeling abnormal—Doxorubicin—bone cancer	0.000185	0.00217	CcSEcCtD
Disopyramide—Pruritus—Methotrexate—bone cancer	0.000184	0.00215	CcSEcCtD
Disopyramide—Urticaria—Doxorubicin—bone cancer	0.000178	0.00209	CcSEcCtD
Disopyramide—Body temperature increased—Doxorubicin—bone cancer	0.000178	0.00208	CcSEcCtD
Disopyramide—Diarrhoea—Methotrexate—bone cancer	0.000178	0.00208	CcSEcCtD
Disopyramide—Asthenia—Epirubicin—bone cancer	0.000174	0.00204	CcSEcCtD
Disopyramide—Pruritus—Epirubicin—bone cancer	0.000172	0.00201	CcSEcCtD
Disopyramide—Dizziness—Methotrexate—bone cancer	0.000172	0.00201	CcSEcCtD
Disopyramide—Diarrhoea—Epirubicin—bone cancer	0.000166	0.00194	CcSEcCtD
Disopyramide—Vomiting—Methotrexate—bone cancer	0.000165	0.00193	CcSEcCtD
Disopyramide—Rash—Methotrexate—bone cancer	0.000164	0.00191	CcSEcCtD
Disopyramide—Dermatitis—Methotrexate—bone cancer	0.000163	0.00191	CcSEcCtD
Disopyramide—Headache—Methotrexate—bone cancer	0.000163	0.0019	CcSEcCtD
Disopyramide—Asthenia—Doxorubicin—bone cancer	0.000161	0.00189	CcSEcCtD
Disopyramide—Dizziness—Epirubicin—bone cancer	0.000161	0.00188	CcSEcCtD
Disopyramide—Pruritus—Doxorubicin—bone cancer	0.000159	0.00186	CcSEcCtD
Disopyramide—Vomiting—Epirubicin—bone cancer	0.000154	0.00181	CcSEcCtD
Disopyramide—Nausea—Methotrexate—bone cancer	0.000154	0.0018	CcSEcCtD
Disopyramide—Diarrhoea—Doxorubicin—bone cancer	0.000154	0.0018	CcSEcCtD
Disopyramide—Rash—Epirubicin—bone cancer	0.000153	0.00179	CcSEcCtD
Disopyramide—Dermatitis—Epirubicin—bone cancer	0.000153	0.00179	CcSEcCtD
Disopyramide—Headache—Epirubicin—bone cancer	0.000152	0.00178	CcSEcCtD
Disopyramide—Dizziness—Doxorubicin—bone cancer	0.000149	0.00174	CcSEcCtD
Disopyramide—Nausea—Epirubicin—bone cancer	0.000144	0.00169	CcSEcCtD
Disopyramide—Vomiting—Doxorubicin—bone cancer	0.000143	0.00167	CcSEcCtD
Disopyramide—Rash—Doxorubicin—bone cancer	0.000142	0.00166	CcSEcCtD
Disopyramide—Dermatitis—Doxorubicin—bone cancer	0.000142	0.00166	CcSEcCtD
Disopyramide—Headache—Doxorubicin—bone cancer	0.000141	0.00165	CcSEcCtD
Disopyramide—Nausea—Doxorubicin—bone cancer	0.000133	0.00156	CcSEcCtD
